Tag: Reassessment

Should FDA Clearance and Supply Chain Risks Drive a Reassessment of Baxter International’s (BAX) Digital Health Strategy?
Digital Health and Medical Technology

Should FDA Clearance and Supply Chain Risks Drive a Reassessment of Baxter International’s (BAX) Digital Health Strategy?

September 29, 2025
admin

Baxter International recently launched the Welch Allyn Connex 360 Vital Signs Monitor in the U.S., featuring…

Continue Reading